Joseph D Panarese

This inventor holds 34 USPTO granted patents and 14 published patent applications and 5 EPO patents, primarily in Antiviral Agents. Top assignee: Enanta Pharmaceuticals, Inc.. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph D Panarese. Retrieved from https://idiyas.com/inventor/joseph-d-panarese

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 34 (Patent Applications = 14)

% Patents Active = 97.1

EPO Patents = 5 (Patent Applications = 11)

Average Co-Inventor Count = 6.1

ph-index = 9

Forward Citations = 201(Granted Patents)

Location History:

Maiden, MA (US) (2020)
Malden, MA (US) (2018 - 2023)
Newton, MA (US) (2022 - 2024)

Company Filing History:

33 out of 299

Enanta Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 2018-2026

Loading Chart...

Areas of Expertise:

Antiviral Agents

Spiropyrrolidine

Benzodiazepine

Functionalized Heterocycles

RSV Inhibitors

Macrocyclic Compounds

Heterocyclic Compounds

Alkyne-Containing

Substituted Heterocycles

Functionalized Peptides

Pharmaceutical Agents

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12540141 - Spiropyrrolidine derived antiviral agents (2026-02-03),

2. 12479854 - Spiropyrrolidine derived antiviral agents (2025-11-25),

3. 12398147 - Macrocyclic spiropyrrolidine derived antiviral agents (2025-08-26),

4. 12297209 - Benzodiazepine derivatives as RSV inhibitors (2025-05-13),

5. 12268694 - Combination pharmaceutical agents as RSV inhibitors (2025-04-08),

6. 12264159 - Functionalized heterocycles as antiviral agents (2025-04-01),

7. 12145941 - Heterocyclic antiviral agents (2024-11-19),

8. 11993600 - Saturated spirocyclics as antiviral agents (2024-05-28),

9. 11976084 - Spiropyrrolidine derived antiviral agents (2024-05-07),

10. 11952389 - Benzodiazepine derivatives as RSV inhibitors (2024-04-09),

11. 11891393 - Functionalized heterocycles as antiviral agents (2024-02-06),

12. 11858945 - Alkyne-containing antiviral agents (2024-01-02),

13. 11802125 - Functionalized heterocyclic compounds as antiviral agents (2023-10-31),

14. 11738019 - Substituted heterocycles as antiviral agents (2023-08-29),

15. 11390631 - Benzodiazepine derivatives as RSV inhibitors (2022-07-19),

Title: The Innovative Journey of Joseph D Panarese

Introduction: Joseph D Panarese, a talented inventor hailing from Malden, MA (US), has made significant contributions to the field of technology through his creative and groundbreaking inventions.

Latest Patents: Joseph D Panarese holds several patents in various technological domains, showcasing his versatility and ingenuity in creating novel solutions to complex problems.

Career Highlights: With a career spanning over two decades, Joseph D Panarese has established himself as a prominent figure in the world of innovation. His work has not only revolutionized industries but has also improved the lives of many through his forward-thinking inventions.

Collaborations: Throughout his career, Joseph D Panarese has collaborated with leading tech companies, research institutions, and universities to further his research and bring his inventions to life. His ability to work in diverse teams has led to the successful development of cutting-edge technologies.

Conclusion: Joseph D Panarese's passion for innovation and his relentless drive to push the boundaries of what is possible have solidified his position as a respected inventor in the technological landscape. His contributions continue to inspire future generations of inventors to think outside the box and create solutions that shape the world we live in.

Profile summary based on public USPTO records.